ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹242 Cr | ₹196 Cr | ₹215 Cr | ₹171 Cr | ₹136 Cr |
What is the latest Sundry Debtors ratio of ORCHID PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹242 Cr |
| Mar2024 | ₹196 Cr |
| Mar2023 | ₹215 Cr |
| Mar2022 | ₹171 Cr |
| Mar2021 | ₹136 Cr |
How is Sundry Debtors of ORCHID PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹242 Cr | 23.67 | |
| Mar2024 | ₹196 Cr | -9.13 | |
| Mar2023 | ₹215 Cr | 26.16 | |
| Mar2022 | ₹171 Cr | 25.70 | |
| Mar2021 | ₹136 Cr | - | |
Compare Sundry Debtors of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹6,013.1 Cr | 6.1% | -2.9% | 43.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 6.1% |
-2.9% |
43.2% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses